HOME >> BIOLOGY >> NEWS
Substances found in blood may predict development of preeclampsia

Abnormal levels of two molecules found in the blood appear to predict the development of preeclampsia, a life-threatening complication of pregnancy, according to a study by researchers at the National Institute of Child Health and Human Development of the National Institutes of Health and the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston. The findings will appear in the February 12 issue of The New England Journal of Medicine but are scheduled for early release on the Journal's Web site at www.nejm.org, to coincide with a presentation at the Society for Maternal-Fetal Medicine Annual Meeting.

When compared to women who did not have preeclampsia, women who later developed the condition had elevated blood levels of a substance known as soluble fms-like tyrosine kinase 1 (sFlt-1), before their preeclampsia occurred. Conversely, beginning early in their pregnancies, these women had lower levels of a substance known as placental growth factor (PlGF) in the blood than did women who did not develop preeclampsia.

Women who developed preeclampsia also had lower levels of another substance, vascular endothelial growth factor (VEGF). The researchers were unable to use VEGF levels to predict the development of preeclampsia; however, VEGF appears to be important for the healthy functioning of blood vessels, and the researchers theorize that the lack of VEGF as well as PlGF contributes to the health problems resulting from preeclampsia.

Preeclampsia can occur suddenly, without warning. Usually, a pregnant woman with preeclampsia develops dangerously high blood pressure and begins excreting protein in the urine. In some cases, the condition may progress to eclampsia, a series of potentially fatal seizures. Although the high blood pressure and seizures can be treated, the only cure for preeclampsia is delivery of the baby. According to the study authors, preeclampsia affects about 5 percen
'"/>

Contact: Bob Bock
bockr@mail.nih.gov
301-496-5134
NIH/National Institute of Child Health and Human Development
5-Feb-2004


Page: 1 2 3 4

Related biology news :

1. Studies Rebut Concept That Body Stores Vitamin A-Making Substances
2. Munching Microbes Make A Meal Out Of Toxic Substances
3. New signs of life found at the Poles
4. Key cell-death step found
5. European common frog found to use novel mating strategy
6. Byproduct of water-disinfection process found to be highly toxic
7. Genuine stem cells found in skin might treat hair loss, wounds
8. Flame retardants found on supermarket shelves
9. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
10. Genetic clues found for common congenital brain disorder
11. New clues to hereditary blinding disease found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2020)... ... ... A team of researchers at the Icahn School of Medicine at Mount Sinai, ... causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering ... efforts are being led by Mone Zaidi, MD, PhD, MACP, Director of the Mount ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... digital transformation and innovation in technology and compliance, announces a new managed service ... best-in-class trio of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) – ...
(Date:4/16/2020)... ... April 15, 2020 , ... With ... to create a vaccine to this novel virus. In an effort to accelerate ... Complex Systems (LRC), is announcing the development of Sample.Exchange, a web-based platform ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer of ... SneakPeek Early Gender DNA Tests sold in March, just months after attaining the ... ecommerce product, where a mom could order her kit online, collect a DNA sample ...
(Date:4/1/2020)... AUSTIN, Texas (PRWEB) , ... March 30, 2020 ... ... MD (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year ... the COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting ...
(Date:4/1/2020)... , ... March 31, 2020 , ... ... (P2) announce the signing of a Joint Development Agreement that builds on ... Research, Inc. is a global leader in the supply of high-quality insect pheromones ...
(Date:3/19/2020)... FREDERICK, Md. (PRWEB) , ... ... ... announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit ... gene-modified cell therapies for ovarian cancer and other solid tumor indications. The ...
Breaking Biology Technology:
Cached News: